ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to
By Dr K. Leelamoni October 16, 2023: Sheela, 19, a student studying medicine in India’s southern city of Thiruvananthapuram, was bitten by a
HQ Team October 13, 2023: Conflict-torn Gaza is running out of food, water, electricity and critical supplies as an Israeli blockade prevents aid
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy
HQ Team October 12, 2023: An estimated five billion people will face inadequate access to water at least a month, every year by
HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA
HQ Team October 12, 2023: A recent study conducted by Boston Children’s Hospital found that more than a third of toddlers diagnosed with
HQ Team October 12, 2023: A new report from the University of Chicago’s Air Quality Life Index has refocused our attention on the
HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people
HQ Team October 10, 2023: Compounded ketamine products used to treat psychiatric disorders, are not safe, may put patients at severe risk of